John Boyer »

Rani Therapeutics Hldgs shares owned by John Boyer

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by John Boyer from 13F filings

Historical chart of John Boyer investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by John Boyer consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by John Boyer

Quarter filed Position value Share count Share price at filing
2026-09-30 $79 100 0.79

More positions owned by John Boyer

Schwab US Broad Market ETF Us Brd Mkt Etf (SCHB)
Vanguard Information Technology ETF Inf Tech Etf (VGT)
SPDR Gold MiniShares Spdr Gld Minis (GLDM)
Vanguard Dividend Appreciation ETF Div App Etf (VIG)
iShares Core S&P Small-Cap ETF Core S&p Scp Etf (IJR)
Schwab US Large-Cap ETF Us Lrg Cap Etf (SCHX)
Schwab US Small-Cap ETF Us Sml Cap Etf (SCHA)
Apple (AAPL)
Schwab US Mid-Cap ETF Us Mid-cap Etf (SCHM)
Altria (MO)
Verizon Communications (VZ)
Amazon (AMZN)
Franklin Resources (BEN)
Pfizer (PFE)
Dominion Resources (D)

View all positions for John Boyer

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
RA Capital Management
AWM Investment Company
Vanguard Capital Management
Longaeva Partners
Polar Securities
Siren
Heights Capital Management
Geode Capital Management
Citadel Advisors
Marshall Wace
Jane Street
Nan Fung Group Holdings
Vanguard Fiduciary Trust
Renaissance Technologies

View all funds holding Rani Therapeutics Hldgs